Immunology
Permanent URI for this collectionhttps://hdl.handle.net/20.500.12503/21738
Browse
Browsing Immunology by Author "Hodge, Lisa"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item Osteopathic Lymphatic Pump Treatment Does Not Alter Antibiotic Distribution in a Rat Model(2015-03) Redman, Charlotte J.; Hodge, LisaPurpose: Osteopathic doctors perform manual medicine treatments to promote the body to self-heal. The lymphatic pump technique (LPT) is one of these treatments and it has been shown to improve lymph circulation and delivery of immune factors. In 2010 we developed a rat model to study the effect of LPT on the lymphatic system. We found that 4 minutes of LPT significantly increased the lymph flow and the concentration of lymphocytes in the lymph. We also found that the combination of LPT and levofloxacin protected against Streptococcus pneumoniae-mediated pneumonia by reducing the concentration of bacteria in the lungs. Furthermore, LPT has been shown to increase the uptake of antigen from the interstitium; therefore, LPT may act as an adjunctive therapy during the treatment of pneumonia by enhancing the uptake and delivery of antibiotics. Specifically, we hypothesized that LPT would increase the concentration of levofloxacin in the lungs. Materials and Methods: Male, Fisher 344 rats with jugular vein catheters weighing between 200-300 grams were used. Rats were injected subcutaneously with 50 mg/kg levofloxacin and randomized into control, sham, or LPT groups. Control rats received no treatment or anesthesia, sham rats received anesthesia for 4 minutes, and LPT rats received LPT under anesthesia for 4 minutes. Ten minutes post-treatment, serum and bronchoalveolar lavage fluid (BALF) were collected and the concentration of levofloxacin was determined using a levofloxacin bioassay. Results: In serum, there was no significant difference (p value= 0.74) in the levofloxacin concentration between control (3.8±0.4 μg/ml), sham (3.9±0.6 μg/ml), or LPT (4.3±0.5 μg/ml). Similarly in the BALF, there was no significant difference (p value= 0.69) in the levofloxacin concentration between control (0.14±0.03 μg/ml), sham (0.10±0.03 μg/ml), LPT (0.12 ±0.03 μg/ml). Conclusion: In conclusion, the results from this experiment suggest that LPT does not enhance the delivery of levofloxacin to the lungs. Alternatively, LPT may act as an adjunctive therapy during the treatment of pneumonia by enhancing immune-mediated protection. Future studies are necessary to test this hypothesis.Item The Role of Lymph Flow on MTLn3 induced Breast Cancer(2015-03) Castillo, Rudy A.; Carter, KiahRae J.; Hodge, LisaPurpose: Secondary lymphedema is the chronic accumulation of lymph with no definitive cure. At least 22 % of axillary lymph node dissection and biopsies in breast cancer (BC) patients can lead to secondary lymphedema. There are no pharmaceuticals approved for lymphedema however manual medicine techniques have been designed to enhance lymph flow. Many clinicians fear manual medicine techniques, such as osteopathic lymphatic pump treatment (LPT), could promote metastasis in BC patients although there is a lack of literature supporting this notion. Our previous studies have shown LPT increases lymph flow and leukocyte concentrations in the lymph of rats. Physical activity increases lymph flow and has been associated with improved quality of life in BC patients and proposed as a modulator of the immune system. Therefore we proposed increasing lymph flow does not promote primary tumor growth. Methods: To determine the effect of LPT on BC, rats were randomized on day 0 into control, sham and LPT groups and injected with MTLn3. The LPT group received LPT under anesthesia, the sham group received anesthesia and the control group did not receive LPT or anesthesia. Treatment was administered once daily at days 14-24 post-injection. At days 0, 7, 14, 21 and 25, primary tumors were excised, measured, weighed and prepared for histological examination. Axillary sentinel lymph nodes (SLN) were excised, weighed and leukocyte populations were measured. Results: In the control rats, tumor weight increased significantly between days 14 (0.06 grams) and 25 (2.86 grams) post-injection. Tumor volume in situ increased significantly between days 14 (1.17 cm3) and 25 (2.75 cm3) post injection. Consistent with tumor growth, immunofluorescent staining revealed angiogenesis between days 14 and 25. Furthermore, SLN weight increased significantly (three-fold increase) and pathology confirmed metastasis by day 25. The number of T cells, B cells, NK cells, dendritic cells and macrophages were significantly higher in the SLN by day 25. LPT did not increase primary tumor size compared to control and sham groups. Interestingly, sham significantly increased SLN size (five-fold increase) when compared to control and LPT decreased SLN size when compared to sham. Conclusions: Our results suggest LPT does not increase primary tumor growth and negated the effect of sham treatment on the sentinel lymph node. Therefore, future studies will focus on how LPT reduces sham induced enlargement and determine if LPT reduces tumor load or fluid in the SLN.